title: Medulloblastoma with myogenic differentiation: long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation.
abstract: Medulloblastoma with myogenic differentiation (MMD) is a rare and aggressive variant of medulloblastoma, occurring predominantly in children. There have been only two case reports of long-term survival previously published. We report a case of long-term disease-free survival in a 21-year-old diagnosed with MMD.
authors.affiliation: Oxford University Medical School, John Radcliffe Hospital, Oxford, UK.
authors.forename: William
authors.initials: W
authors.lastname: Rattenberry
authors.forename: Colleen H
authors.initials: CH
authors.lastname: McDonough
authors.forename: Peter C
authors.initials: PC
authors.lastname: Burger
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Cohen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002454:Cell Differentiation; D002528:Cerebellar Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D019635:Neurosurgical Procedures; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous; D055815:Young Adult